OmniAb
Yahoo Finance • 8 days ago
OmniAb Jumps 18% as Lilly Deal Lifts Cash Outlook
This article first appeared on GuruFocus. OmniAb Inc. (OABI, Financials) shares soared almost 18% in premarket trade after the company raised its cash forecast for 2026 on the back of recent license and business-development agreements.The... Full story
Yahoo Finance • 8 days ago
Top Midday Gainers
OmniAb (OABI) unveiled a partnership with Eli Lilly (LLY) on a new ion-channel drug discovery program, while raising its fiscal 2026 cash and cash equivalents guidance. Shares of OmniAb jumped over 11%, with intraday trading volume rising... Full story
Yahoo Finance • 8 days ago
OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company
EMERYVILLE, Calif., August 17, 2026--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation therapeutics, today announced a global collaboration and... Full story
- LLY
Mentioned:
Yahoo Finance • 18 days ago
OmniAb Inc (OABI) (Q2 2026) Earnings Call Highlights: Revenue Surges 243% as Two Programs Leap ...
This article first appeared on GuruFocus. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points OmniAb Inc (NASDAQ:OABI) reported a strong sec... Full story
- ARGX
Mentioned:
Yahoo Finance • 2 months ago
The Cancer Therapy Strategy VERAXA Is Betting the Company On
By Karen Roman VERAXA Biotech AG (Nasdaq: VRXA) said it expects BiTAC molecules to be the company's main value drivers and to dominate its pipeline development in the upcoming years, hence receiving VERAXA's main share of investments to h... Full story
Yahoo Finance • 5 months ago
OmniAb (OABI) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool. Date March 4, 2026, at 4:30 p.m. ET Call participants President and Chief Executive Officer — Matthew W. FoehrChief Financial Officer — Kurt A. Gustafson Takeaways Active partners -- Reached 107 by year... Full story
Yahoo Finance • 10 months ago
OmniAb outlines $18M–$22M 2025 revenue guidance while launching OmniUltra and expanding xPloration platform
Earnings Call Insights: OmniAb, Inc. (OABI) Q3 2025 MANAGEMENT VIEW * CEO Matthew Foehr reported continued strong deal flow in the third quarter with new program additions for 2025 already matching the total from all of 2024. He highli... Full story
Yahoo Finance • last year
OmniAb Q2 2025 slides: Partner growth accelerates despite revenue decline
OmniAb Inc. (NASDAQ:OABI) presented its second-quarter 2025 financial results and business update on August 6, revealing a company experiencing robust partner and program growth despite financial challenges. The antibody discovery platform... Full story
Yahoo Finance • 2 years ago
OmniAb Inc (OABI) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ...
Total Revenue: $7.6 million for Q2 2024, compared to $6.9 million in the prior year quarter. Service Revenue: Included an accelerated $1.3 million due to the discontinuation of the GSK small molecule ion channel program. R&D Expense: Relat... Full story
Yahoo Finance • 3 years ago
These 2 ‘Strong Buy’ Penny Stocks Are Poised for a Massive Rally, Say Analysts
For investors, the stock market is always a game of risk and reward, and no segment exemplifies that better than the penny stocks. Defined as stocks trading at a price of less than $5, the pennies bring an ultra-low cost of entry to the ta... Full story